PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Essential oil used as a lotion or ointment significantly improved bleeding, permanent pain, pain during defecation, anal irritation, itching, and heaviness, including in patients unresponsive to chemical treatments [PMID:28844211].
A split-face clinical trial compared a Myrtle formula to 1% clindamycin topical solution for efficacy and safety over 16 weeks [PMID:33408898].
Crude preparations showed antibacterial activity against S. aureus, P. mirabilis, P. vulgaris, Klebsiella, S. typhi, P. aeruginosa, Shigella, and E. coli [PMID:18711991].
Essential oil demonstrated ovicidal effects against Haemonchus contortus (IC50 = 0.7 mg/mL) and anthelmintic potential against Heligmosomoides polygyrus [PMID:35779645].
Aqueous and methanolic extracts of berries significantly reduced the ulcer index in ethanol, indomethacin, and pyloric ligation models [PMID:20197454].
Evidence summary
PubMed sources
- 1.PMID: 37464095 (2023) — A review of the biological effects of Myrtus communis. · Physiological reports
- 2.PMID: 30103510 (2018) — Antioxidant Activity of Myrtus communis L. and Myrtus nivellei Batt. & Trab. Extracts: A Brief Review. · Medicines (Basel, Switzerland)
- 3.PMID: 35779645 (2022) — Assessment of anthelmintic potentials of Myrtus communis against Haemonchus contortus and Heligmosomoides polygyrus. · Experimental parasitology
- 4.PMID: 38319389 (2024) — The therapeutic value of Myrtus communis L.: an updated review. · Naunyn-Schmiedeberg's archives of pharmacology
- 5.PMID: 28844211 (2017) — Effectiveness of Myrtus communis in the treatment of hemorrhoids.